ARCHIVES

Benefit Seen In Novel Drug That Treats Gleevec Resistance

This article is from The Cancer Letter archive.

Vol. 28 No. 4 | April 29, 2005

Download PDF Visit The Full Archive

Related Articles

Workshop Suggests Confirmation of Vitamin C Studies

December 7, 1990

Trials Approved by NCI CTEP For the Month of May

May 25, 2012

“Our Job Is to Be The One Agency That Speaks To Cancer”

October 28, 1994

Study Finds Short Term Tests Predict Carcinogenicity

April 25, 1980

ASCO Recommends Beginning Palliative Care Alongside Standard Therapy in Metastatic NSCLC

February 24, 2012

Patient Advocacy: Committee To Advise NCI On Formation Of Liaison Group

February 28, 1997